htai disinvestment early awareness interest group
play

HTAi DISINVESTMENT & EARLY AWARENESS INTEREST GROUP Business - PowerPoint PPT Presentation

HTAi DISINVESTMENT & EARLY AWARENESS INTEREST GROUP Business Meeting June 18, 2019 18:00-19:00 (CET) session IG09 Agenda 1: Welcome and introductions of Executive Team 2: Interest group activities 3: Topic submission for next funding


  1. HTAi DISINVESTMENT & EARLY AWARENESS INTEREST GROUP Business Meeting June 18, 2019 18:00-19:00 (CET) session IG09

  2. Agenda 1: Welcome and introductions of Executive Team 2: Interest group activities 3: Topic submission for next funding cycle 4: Introduction of incoming chairs 5: EuroScan activities 6: Disinvestment toolkit 7: WHO decommissioning book 8: Questions 9: Adjournment

  3. Disinvestment and Early Awareness IG Executive Team Chairs: Julie Polisena and Vigdis Lauvrak Executive Committee: Rosmin Esmail, Roberta Joppi, Iñaki Gutierreza Ibarluzea, Hans-Peter Dauben, Brian Godman Technical Officer: Anna Lien Espeland

  4. Interest Group Activities • Disinvestment Toolkit • Survey on Disinvestment Activities & Candidates in the HTA Community • Current Awareness Alerts

  5. Interest Group Activities: Peer-Reviewed Publication

  6. Interest Group Activities: Current Awareness Alerts • New research on disinvestment and early awareness • Single awareness service • Systematic and comprehensive literature searches

  7. Topic Submission for Next Funding Cycle • Collaboration with IGs or external groups • Topic relevant to HTA community • Funding proposal • Submission deadline in summer 2019

  8. Introduction of Incoming Chairs Chair: Rosmin Esmail Vice-Chair: Antonio Migliore New Executive Team Member: Pricivel Carrera

  9. Update on the EuroScan activities Antonio Migliore AGENAS, Italian national agency for regional healthcare Scientific Director of EuroScan International Network

  10. EuroScan International Network Services Internal Established in 1997 as a collaborative international Affairs network of public agencies; Acquired legal status (nonprofit) in 2017. A scientific non-profit association aimed to:  Collect and share information on emerging, new and obsolete health technologies. External  Be the main global forum for the development of Partnerships methods to identify emerging, new and obsolete health technologies.  Support and promote early awareness systems.

  11. Update on Services  Methodological Toolkit for new and emerging technologies ---> Available in:  Methodological Toolkit for disinvestment ---> Work in progress (with HTAi);  EuroScan website www.euroscan.org ---> Platform to manage information sharing among member;  EuroScan Database ---> Redesign is ongoing (new elements such as ICHI codes);  News feed ---> Metasearch in a list of selected sources. Update on Internal Affairs  Periodic Scientific Meetings ---> Spring & Autumn + General Assembly (during HTAi);  Working Groups ---> WG-MT for medical technologies; WG-PT for pharmaceuticals;  Sources for identification of new and emerging technologies  Definition of the new EuroScan Database structure  Member profiling  Health Interventions and Technologies Journal (HInT)

  12. Update on External Partnerships MoU between EuroScan and relevant partners  WHO; HTAi; INAHTA; RedeTSa; HTAsiaLink ---> Survey on disinvestment with HTAi. Partnerships within EU Horizon 2020 research and innovation programme SAFE-N-MEDTECH - Safety testing in the life cycle of nanotechnology-enabled medical technologies for health https://cordis.europa.eu/project/rcn/221200/factsheet/en  Aimed to build an innovative open access platform to offer to companies and reference laboratories, the capabilities, know-how, networks and services required for the development, testing, assessment, up-scaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices.  27 partners; 2019-2023; EU contribution: 14 billion EUR EU-PEARL - EU Patient-cEntric clinicAl tRial pLatform https://eu-pearl.eu/  Aimed to create a reusable, accessible and sustainable modular integrated research platform (IRP) in Europe for the design and execution of patient-centric, platform trials not limited to one compound or company and to set up an open, dynamic patient inclusive governance structure necessary to deliver the appropriate regulatory, ethical, legal, statistical and data utilisation requirements of the IRP. Four case- study: Major Depressive Disorder, Tuberculosis, Non-Alcoholic Steatohepatitis, and Neurofibromatosis.  36 partners; 2019-2023; EU contribution: 26 billion EUR

  13. Disinvestment Toolkit

  14. WHO Decommissioning Book • WHO medical device technical series Chapter on disinvestment • • Anticipated publication in summer 2019

  15. Questions

  16. Adjournment Email: interestgroups@htai.org Webpage: https://htai.org/interest-groups/disinvestment-and- early-awareness/

Recommend


More recommend